Cargando…
Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer
BACKGROUND: N6-methyladenosine (m6A) modification is the most abundant reversible methylation modification in eukaryotes, and it is reportedly closely associated with a variety of cancers progression, including colorectal cancer (CRC). This study showed that activated lipid metabolism and glycolysis...
Autores principales: | Ye, Mujie, Chen, Jinhao, Lu, Feiyu, Zhao, Minghui, Wu, Suwen, Hu, Chunhua, Yu, Ping, Kan, Jingbao, Bai, Jianan, Tian, Ye, Tang, Qiyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424385/ https://www.ncbi.nlm.nih.gov/pubmed/37580808 http://dx.doi.org/10.1186/s13578-023-01100-9 |
Ejemplares similares
-
ALKBH5 enhances lipid metabolism reprogramming by increasing stability of FABP5 to promote pancreatic neuroendocrine neoplasms progression in an m6A-IGF2BP2-dependent manner
por: Chen, Jinhao, et al.
Publicado: (2023) -
Novel insights into the interplay between m6A modification and programmed cell death in cancer
por: Chen, Jinhao, et al.
Publicado: (2023) -
FABP5 suppresses colorectal cancer progression via mTOR-mediated autophagy by decreasing FASN expression
por: Ye, Mujie, et al.
Publicado: (2023) -
m(6)A reader IGF2BP2-stabilized CASC9 accelerates glioblastoma aerobic glycolysis by enhancing HK2 mRNA stability
por: Liu, Hongjiang, et al.
Publicado: (2021) -
FABP5 regulates lipid metabolism to facilitate pancreatic neuroendocrine neoplasms progression via FASN mediated Wnt/β‐catenin pathway
por: Lu, Feiyu, et al.
Publicado: (2023)